Skip to main content

Samanes Agreda, Gloria

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Samanes Agreda, Gloria

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice.

Related professionals

Enzamaría Fidilio Meli

Enzamaría Fidilio Meli

Predoctoral researcher
Diabetes and Metabolism
Read more
Efráin Santiago Cordero Vázquez

Efráin Santiago Cordero Vázquez

Predoctoral researcher
Diabetes and Metabolism
Read more
Maria Victoria Gonzalez Martinez

Maria Victoria Gonzalez Martinez

Senior researcher
Therapeutics and Innovations in Neuropediatrics and other paediatric rare diseases
Read more
Mónica López Bardasco

Mónica López Bardasco

Administrative
Labour Relations Unit
Human Resources Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.